Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

EGF controls hair growth by regulating hair follicles' growth phases.

AP-1 controls tumor cell type by affecting key signaling pathways.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

Hsc70 protein may influence hair growth by responding to androgens.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Scientists created keratinocyte cell lines from human hair that can differentiate similarly to normal skin cells, offering a new way to study skin biology and diseases.

Researchers created a long-lasting mouse skin cell strain that may help with hair growth research and treatments.

SVpgC2a cells show abnormal growth and keratin changes, modeling early cancer development.

A stable sheep ovarian cell line was created for studying reproduction and hormones.

LGD1069 effectively prevents breast tumors in mice without toxicity.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Bilobetin may help reduce acne by decreasing sebum production.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Proteolytic enzymes damage hair follicles by detaching stem cells.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

Increasing mir-302 turns human hair cells into stem cells by changing gene regulation and demethylation.